Trexquant Investment LP Recursion Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $460,269 - $691,120	71,693 Added 55.72%	200,366 $1.34 Million
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $836,810 - $1.48 Million	116,873 Added 990.45%	128,673 $992,000
Q3 2022 Nov 14, 2022	SELL	$7.83 - $13.6 $332,438 - $577,415	-42,457 Reduced 78.25%	11,800 $126,000
Q2 2022 Aug 11, 2022	BUY	$5.04 - $9.26 $273,455 - $502,419	54,257 New	54,257 $442,000
Q1 2022 May 13, 2022	SELL	$6.16 - $18.03 $74,228 - $217,261	-12,050 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $194,487 - $263,413	12,050 New	12,050 $206,000

303

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.35B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.